Trials / Sponsors / FluGen Inc
FluGen Inc
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Olde Influenza Vaccine | Phase 1 | 2022-06-14 |
| Completed | Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Influenza Vaccine | Phase 1 | 2021-06-30 |
| Completed | Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines Influenza A | Phase 1 | 2019-09-03 |
| Completed | Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers Flu | Phase 1 | 2016-06-01 |
| Completed | Intracutaneous Delivery of Varied Dose Volumes of Saline Influenza | N/A | 2012-12-01 |
| Completed | Site Selection for Intracutaneous Saline Delivery Intracutaneous Drug Delivery | N/A | 2012-12-01 |